Cargando…
Identification of proteins associated with paclitaxel resistance of epithelial ovarian cancer using iTRAQ-based proteomics
Chemotherapy is an important adjuvant therapy for epithelial ovarian cancer (EOC). The main cause of chemotherapy failure in EOC is paclitaxel resistance. The present study aimed to identify novel biomarkers to predict chemosensitivity to paclitaxel and improve our understanding of the molecular mec...
Autores principales: | Wang, Yuanjing, Li, Hongxia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6004651/ https://www.ncbi.nlm.nih.gov/pubmed/29928353 http://dx.doi.org/10.3892/ol.2018.8600 |
Ejemplares similares
-
Understanding Ovarian Cancer: iTRAQ-Based Proteomics for Biomarker Discovery
por: Swiatly, Agata, et al.
Publicado: (2018) -
Quantitative proteomic analysis by iTRAQ(® )for the identification of candidate biomarkers in ovarian cancer serum
por: Boylan, Kristin LM, et al.
Publicado: (2010) -
i-Tracker: For quantitative proteomics using iTRAQ™
por: Shadforth, Ian P, et al.
Publicado: (2005) -
Identification of proteins associated with pyrethroid resistance by iTRAQ-based quantitative proteomic analysis in Culex pipiens pallens
por: Wang, Weijie, et al.
Publicado: (2015) -
Identification of Urinary Biomarkers for Exercise-Induced Immunosuppression by iTRAQ Proteomics
por: Xu, Guoqin, et al.
Publicado: (2020)